United States · FDA National Drug Code directory
Plerixafor
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-373_447a1ba3-4d5e-f506-e063-6394a90aab72
- Product NDC
- 31722-373
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Plerixafor
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250616
- Source listing expiry
- 20261231
Source-listed ingredients
- PLERIXAFOR — 24 mg/1.2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (31722-373-31) / 1.2 mL in 1 VIAL, SINGLE-USE · 31722-373-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →